Jenburkt Pharmaceuticals LtdBSE: JENBURPH

Jenburkt Pharmaceuticals Ltd Press Release May 20 2025

· Issued by Jenburkt Pharmaceuticals Ltd via BSE India

Filed with BSE ·

The Board of Directors of the Company recomended a dividend of Rs.18/- (180%) per equity share of Rs. 10/- each on 4413300 equity shares of the Company, for the Financial year 2024-25, subject to the approval of members at the ensuing 40th Annual General Meeting of the Company.

View Attachment

6ix hasn’t read this filing yet.

Jenburkt Pharmaceuticals Ltd on 6ix

Earlier from Jenburkt Pharmaceuticals

Later from Jenburkt Pharmaceuticals

All Jenburkt Pharmaceuticals news releases